Galaxy Biomedical Investment Co., Ltd.

Sümbol: 000806.SZ

SHZ

0.43

CNY

Turuhind täna

-1.1415
P/E suhe
0.0445
PEG suhe
494.96M
MRK Cap
0.00%
DIV tootlus

Galaxy Biomedical Investment Co., Ltd. (000806-SZ) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Galaxy Biomedical Investment Co., Ltd. (000806.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Galaxy Biomedical Investment Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
balance-sheet.row.cash-and-short-term-investments	81.1	84.6	134.8	100.4	50.7	265.9	470	569.9	312	83	120.5	203.5	347.1	211.2	114.5	146.7	88.5	234.2	336.9	561.3	620.4	165.4	90.5	80.5	40.3	9.6	1.8	1.1	1.6
balance-sheet.row.short-term-investments	3.1	-64.1	24.8	-53.9	-54.4	0	67.3	0	0	0	0	0	59	0	0	0.6	0	1.3	0	1.6	51.7	0.9	0	34	0	0	0	0	0
balance-sheet.row.net-receivables	1177.4	759.4	1146.2	696.1	1414.1	1208.3	725.7	778.2	747.4	689.6	783.9	945.8	1442.6	1747.5	1265.7	1292.5	1140.1	978.8	1060	859.5	564.5	378.5	180.2	54.9	45.3	17.2	11.2	16.6	13.4
balance-sheet.row.inventory	199.6	280.5	233.4	259.5	230.2	482.7	455.9	390.4	329.3	311.9	252.1	351.1	285.1	319.1	379.9	328.6	399.7	315.2	274.8	249.3	155.8	136.3	63.5	45.9	79.2	51.9	55.7	33.2	38.5
balance-sheet.row.other-current-assets	4.7	8	5.5	8.8	21	156.4	144.9	70	2.3	0.7	-105.3	0.5	-271.8	-360.8	0.1	0.5	0	0	119.8	-270	0.8	1	159.5	106.6	89.7	52	30.4	25	16
balance-sheet.row.total-current-assets	1462.8	1132.4	1519.9	1064.8	1716.1	2113.3	1796.5	1808.4	1390.9	1085.2	1051.1	1500.9	1803	1917	1760.1	1768.3	1628.4	1528.3	1791.5	1400.2	1341.4	681.2	493.6	287.9	254.5	130.6	99	76	69.5
balance-sheet.row.property-plant-equipment-net	253.5	285.9	274.1	283	308.8	328.7	377.8	377.4	385.5	412.1	440.5	451.5	456.2	414.7	902.5	1021.6	1383.9	1396.3	974.5	869.1	670.4	398.2	267.5	218.5	192.4	82.1	78.4	68.9	32.2
balance-sheet.row.goodwill	0	0	0	0	0	27.3	165.1	189.1	26	26	26	26	26	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	113	115.9	121.4	125	127.9	157.7	170.2	188.8	212.3	222	232.3	249.8	266	238.6	237	228.1	84.6	94.1	63	62.7	22	14.3	12.8	11.5	5.8	4.8	1.2	1.4	1.5
balance-sheet.row.goodwill-and-intangible-assets	113	115.9	121.4	125	127.9	185	335.3	377.9	238.3	247.9	258.3	275.8	292	238.6	237	228.1	84.6	94.1	63	62.7	22	14.3	12.8	11.5	5.8	4.8	1.2	1.4	1.5
balance-sheet.row.long-term-investments	91.4	178.5	96.2	210.6	292.4	329.7	41.1	77.4	103.3	197.3	220.3	168.5	134.7	320.4	0	638.6	0	266.4	0	153.5	75.7	99	0	-20.5	0	0	0	0	0
balance-sheet.row.tax-assets	19.2	21.3	29.1	25.9	28.3	58.6	40.2	48.7	75.2	79.8	79.5	82.1	74.5	53.8	68.4	63	0	3.3	0	0	58.5	5.2	0	34.3	0	0	0	0	0
balance-sheet.row.other-non-current-assets	66.6	2.2	85.8	9.7	8.6	677.7	295.7	87.4	114.9	257.9	281	229.2	140.9	381	301.8	48.6	288.6	3.9	223.6	7	72.6	20.2	108.8	67.2	11.1	9	9.4	9.3	9.4
balance-sheet.row.total-non-current-assets	543.7	603.8	606.7	654.3	766	1250	1090	891.4	813.8	997.9	1059.3	1038.7	1098.3	1088.2	1509.6	1975.6	1757.1	1760.7	1261.1	1092.4	840.7	531.7	389.1	276.7	209.3	95.9	89	79.6	43.2
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	2006.5	1736.2	2126.6	1719.1	2482.1	3363.3	2886.5	2699.8	2204.8	2083.1	2110.4	2539.6	2901.4	3005.2	3269.8	3743.8	3385.5	3289	3052.6	2492.5	2182.2	1212.9	882.7	564.7	463.8	226.5	188	155.6	112.6
balance-sheet.row.account-payables	285.4	261	304.1	339.8	265.8	295.2	301	289.7	453.2	271	226.3	260	242.1	193.5	318.6	156.7	216.6	98.9	173.5	165.9	99.5	51.9	17.9	8.8	19	7.7	30.5	19.8	8.4
balance-sheet.row.short-term-debt	189.2	109.3	99.4	122.2	530.5	229	209	95	628	517.9	497	761.7	725.4	827.2	1065.6	1037	1268.3	1401.8	1062	933.8	688.7	505.7	314	65	46.3	50.7	15	13.3	4.7
balance-sheet.row.tax-payables	45.5	28.7	20.6	10	11.5	20.9	12.8	16.1	15.9	9.9	7.4	4.1	21.3	22.9	22.8	45.1	5.1	14.6	23.4	17.3	18	20.1	12.7	20.1	15.5	4.6	7.4	3.1	3
balance-sheet.row.long-term-debt-total	9.3	10.6	59	60	0	380	30	0	64	174	296.5	296.5	542.5	340.1	290.2	355.6	421.3	221.7	238.5	201.7	117.1	91.3	92.6	111.6	66.6	0	0	0	0
Deferred Revenue Non Current	36.3	41.2	44.4	52.4	52.6	58.6	56	57.2	55.7	1.5	1.5	2.8	23.6	88.7	36.4	36.5	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	569	18.1	310.2	460.8	228.8	213.2	178.1	189.9	151.7	183.4	144.3	306	226	296.7	402.4	504.1	339.6	257.3	237.7	-94.2	141.4	102.2	68.5	60.5	30.3	14.2	27.7	40.4	25.6
balance-sheet.row.total-non-current-liabilities	2205.7	1830.1	924.8	485.5	55	449.2	86.6	57.3	129.1	249	377	379	659.9	478.5	362.9	469.9	463.6	266.5	281.6	244.1	158.6	100.1	101.5	120.8	82.2	0	0	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	8.7	10.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	3249.4	2631.1	2063.9	1701.1	1091.5	1186.6	774.6	631.9	1362	1221.3	1244.5	1706.6	1853.5	1795.9	2149.5	2167.8	2288.1	2024.5	1754.9	1249.6	1088.2	759.9	501.8	255.1	177.8	72.6	73.2	73.5	38.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	699.2	699.2	699.2	699.2	699.2	699.2	699.2	635.6	635.6	418.7	349	303.4	303.4	211.6	211.6	162.8	82.2	61.2	61.2	61.2	61.2
balance-sheet.row.retained-earnings	-3534.5	-3175	-2195.6	-2253.9	-908.3	-202.7	-212.3	-225.2	-327.7	-353.8	-366	-390.1	-211.7	-137.5	-177.5	27.3	-34.6	158.2	158.9	208.2	133.2	113.8	58	53.5	65.1	40.4	18	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	1181.5	1189.5	1162.6	1178.1	1194.3	1208.7	1146.1	1138.1	447.5	490	506.4	499.3	525.7	611.1	560.6	859.2	461.8	663.1	768.4	713	643.2	119.1	102	83.9	129.4	27.8	23.8	12.9	5
balance-sheet.row.total-stockholders-equity	-1253	-885.6	66.9	24.1	1385.9	2105.9	2033.8	2012.8	819	835.5	839.7	808.5	1013.2	1172.7	1082.3	1522.1	1062.8	1240	1276.3	1224.6	1079.8	444.5	371.6	300.2	276.7	129.4	103	74.1	66.2
balance-sheet.row.total-liabilities-and-stockholders-equity	2006.5	1736.2	2126.6	1719.1	2482.1	3363.3	2886.5	2699.8	2204.8	2083.1	2110.4	2539.6	2901.4	3005.2	3269.8	3743.8	3385.5	3289	3052.6	2492.5	2182.2	1212.9	882.7	564.7	463.8	226.5	188	157.6	112.6
balance-sheet.row.minority-interest	10.2	-9.3	-4.2	-6.1	4.7	70.8	78.1	55.1	23.8	26.3	26.2	24.5	34.7	36.5	37.9	53.9	34.6	24.4	21.4	18.3	14.1	8.6	9.4	9.4	9.3	24.6	11.8	9.9	7.8
balance-sheet.row.total-equity	-1242.8	-894.9	62.7	18	1390.6	2176.7	2111.9	2067.9	842.8	861.8	865.9	832.9	1047.9	1209.3	1120.2	1576.1	1097.4	1264.4	1297.7	1242.9	1094	453	381	309.6	286	154	114.8	84	73.9
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	94.5	114.4	121	156.7	238	208.9	108.4	74	101.7	196.5	219.4	163.5	193.7	295.1	275.6	639.2	286.7	267.7	219.8	155.1	127.5	99.9	87.1	13.5	9.1	0	0	0	0
balance-sheet.row.total-debt	198.5	119.9	158.4	182.2	530.5	609	239	95	692	691.9	793.5	1058.2	1267.9	1167.3	1355.8	1392.6	1689.6	1623.5	1300.5	1135.5	805.8	597	406.6	176.6	112.8	50.7	15	13.3	4.7
balance-sheet.row.net-debt	120.5	35.3	48.4	81.8	479.8	343.1	-163.8	-474.9	380	608.8	673	854.7	979.8	956	1241.3	1246.5	1601	1390.6	963.6	575.8	237.1	432.5	316.1	130	72.5	41.1	13.2	12.2	3.1

Rahavoogude aruanne

Galaxy Biomedical Investment Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	-336.6	-968.5	62.1	-1169.5	-736.3	14.6	16.4	102.6	23	12.4	25.9	-187.6	-57.6	51.4	-185.6	26.2	-180.9	10.2	143.2	127.4	79	93.4	89	49.2	30.7
cash-flows.row.depreciation-and-amortization	46.9	47.4	28.2	32.1	44.3	42.7	42.2	57.5	46.7	46.6	46.5	49.2	47.8	45.6	85.8	100.8	87.5	86.6	62.4	33.3	27.8	18.8	18.6	15.7	5.3
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-229.6	-94.8	-74.1	345.8	-140.5	-124.9	15.8	-140.4	-11.2	-8.4	250.8	214	142.8	-286.7	-228.9	-73.6	-127.6	-197.2	-319.4	1.6	-71.3	-69.8	-84.7	-76.6	-39.7
cash-flows.row.account-receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	80.9	-47.7	26.7	-22.1	89.4	-24.1	-65.5	-61.1	-17.4	-59.8	99	-66	37.1	60.8	-52.2	72.7	-97.6	-42.6	-25.4	-93.6	31	-72.9	-17.6	-6.8	-20.4
cash-flows.row.account-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-310.5	-47.1	-100.8	367.9	-229.9	-100.8	81.3	-79.3	6.2	51.4	151.8	280	105.7	-347.5	-176.7	-146.3	-30.1	-154.6	-294	95.1	-102.3	3	-67.1	-69.9	-19.3
cash-flows.row.other-non-cash-items	485.3	988.5	28.5	854.9	468.2	0.5	12	-117.4	-9.2	13.4	-19.9	181.3	118.5	-5	297.9	128.2	174.5	122.1	39.2	14.3	28.2	20.5	10	1	6.1
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-7	-22.1	-18.6	-11.4	-13.9	-65.2	-38.5	-20	-9.3	-8.4	-23.3	-59.9	-124.3	-126.4	-18.4	-15.9	-112.5	-104.6	-181.7	-251.4	-253.8	-96.9	-169.2	-16	-98
cash-flows.row.acquisitions-net	0	0.8	19.6	19.2	97.5	0.7	0.4	-166	0	0	0	11.1	0.9	396.4	27.9	0	8.5	0	181.8	264.6	3.3	0.2	0	16	99.8
cash-flows.row.purchases-of-investments	-64.7	-282.3	-220.1	-170.1	-263.8	-1142.3	-570.9	-216.9	-3	0	-65	-0.5	-105.6	-10	-13	-7.1	-0.8	-79.1	-74.8	-151.6	-145.8	-58.3	-76.2	-55.5	-2.1
cash-flows.row.sales-maturities-of-investments	77.2	315.6	212.9	202.8	372.6	795.7	199.2	285.7	138.6	63.5	23.3	118.2	22.8	243.4	95.4	142	2.3	6.9	14	194.5	56.1	3.2	52.7	30.9	5.1
cash-flows.row.other-investing-activites	1.3	2.2	-18.6	1.5	13.6	31.7	6.4	43.5	-9.2	15	15.4	14.3	69.1	26.3	15.1	127.5	15.1	3.1	0	13.2	3	0.3	2.7	0	1.8
cash-flows.row.net-cash-used-for-investing-activites	6.9	14.4	-24.8	41.9	205.9	-380.1	-403.8	-73.7	117.1	70.1	-49.6	72.1	-137.1	529.7	107.1	246.5	-95.9	-173.8	-242.5	-195.3	-340.6	-151.8	-190	-40.5	-93.2
cash-flows.row.debt-repayment	-80.9	-25	-26	-131.9	-162	-424	-105	-708	-736.8	-585.8	-873.3	-998.2	-1145.8	-884.4	-419.5	-764.9	-1233.1	-1539	-847.2	-848.7	-648.8	-379.5	-111	-44.8	-117.8
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-4.7	-4.8	-8	-17	-35.1	-15.2	-7.1	-17.6	-50.1	-52.4	-73.2	-110.4	-170.2	-112.8	-64.6	-58.6	-101.1	-86.4	-70.7	-49.9	-43.5	-48.9	-25.5	-7.2	-16.4
cash-flows.row.other-financing-activites	104	19.7	21.6	77.6	159.5	763.7	260.7	1250.7	732.8	481.4	605.6	762.4	1216.8	713	376.2	452.7	1332.3	1673.4	1012.2	908.4	1373.3	577.8	337.3	111.8	251.5
cash-flows.row.net-cash-used-provided-by-financing-activities	18.4	-10.1	-12.4	-71.3	-37.6	324.5	148.5	525.2	-54.1	-156.8	-340.9	-346.1	-99.2	-284.2	-108	-370.8	-1.9	48.1	94.4	9.8	681	149.3	200.9	59.8	117.4
cash-flows.row.effect-of-forex-changes-on-cash	0.3	-0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5
cash-flows.row.net-change-in-cash	-8.4	-23	7.5	33.9	-195.9	-122.6	-168.9	353.8	112.5	-22.7	-87.3	-17.2	15.3	50.8	-31.6	57.2	-144.3	-104	-222.8	-8.9	404.1	60.4	43.9	8.5	26.9
cash-flows.row.cash-at-end-of-period	42.2	50.6	73.6	66.1	32.2	228.1	350.7	519.7	165.9	53.4	76.1	163.4	180.6	165.3	114.5	146.1	88.5	232.9	336.9	559.7	568.6	165.4	90.5	46.6	40.3
cash-flows.row.cash-at-beginning-of-period	50.6	73.6	66.1	32.2	228.1	350.7	519.7	165.9	53.4	76.1	163.4	180.6	165.3	114.5	146.1	88.9	232.9	336.9	559.7	568.6	164.5	105	46.6	38	13.4
cash-flows.row.operating-cash-flow	-34	-27.3	44.7	63.2	-364.3	-67.1	86.4	-97.7	49.4	64	303.3	256.9	251.6	-194.7	-30.7	181.5	-46.6	21.7	-74.7	176.6	63.6	62.8	33	-10.7	2.3
cash-flows.row.capital-expenditure	-7	-22.1	-18.6	-11.4	-13.9	-65.2	-38.5	-20	-9.3	-8.4	-23.3	-59.9	-124.3	-126.4	-18.4	-15.9	-112.5	-104.6	-181.7	-251.4	-253.8	-96.9	-169.2	-16	-98
cash-flows.row.free-cash-flow	-41	-49.3	26.1	51.8	-378.3	-132.3	47.9	-117.6	40.1	55.6	279.9	197	127.3	-321.1	-49.1	165.6	-159.1	-82.9	-256.4	-74.8	-190.1	-34.1	-136.2	-26.7	-95.7

Kasumiaruande rida

Galaxy Biomedical Investment Co., Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 000806.SZ brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
income-statement-row.row.total-revenue	1528	1144.1	1106	781.4	761.3	1045.7	1204.6	832.4	801.9	784.1	957.3	957.6	976.7	1019.3	1754.9	1750.4	1015.2	987.8	1008.2	784.5	631.1	401.1	283.8	165.2	148.1	133	125.1	102.3	61.3
income-statement-row.row.cost-of-revenue	985.4	718.3	720.8	566.8	603.9	756.2	889.3	610.7	587.1	563.5	736.5	817.9	740.1	743.5	1320	1314.5	815.5	691.9	748.1	554.8	448.5	224.2	141.1	96.9	95.8	75.3	78	67.4	39.6
income-statement-row.row.gross-profit	542.6	425.8	385.2	214.6	157.3	289.5	315.3	221.7	214.8	220.6	220.8	139.7	236.6	275.9	434.9	435.9	199.8	295.9	260.1	229.7	182.6	176.9	142.8	68.3	52.3	57.6	47.2	34.9	21.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	101.3	94.5	41.9	90.8	-3.2	5.9	12.4	42.4	-2.3	3.6	12.1	9.9	21.1	3.8	6.5	5.3	-3.3	9.5	-4.8	6.6	8.2	2.4	2.3	16.1	8.2	0	4.2	3.8	3.6
income-statement-row.row.operating-expenses	298.4	338.1	201.8	320.7	390.5	288	282.8	246.3	189.9	188.2	212.7	232.7	210	207.4	305.1	271.9	240.8	218.9	188.1	121.2	87.9	60.2	44.3	22.8	20	8.8	6.4	3.8	5
income-statement-row.row.cost-and-expenses	1283.7	1056.4	922.6	887.6	994.5	1044.2	1172.1	856.9	777	751.7	949.3	1050.6	950.1	950.9	1625.1	1586.4	1056.3	910.8	188.1	676	536.4	284.3	185.4	119.7	115.8	84.2	84.3	71.1	44.6
income-statement-row.row.interest-income	0.2	0.3	0.2	0.2	0.3	2.1	4.3	5.7	0.9	0.4	1.3	1.5	1.4	0	0.6	1.4	6	3.9	18.4	5.4	9.5	1.3	2.7	0	0	0	0	0	0
income-statement-row.row.interest-expense	18.9	14.5	20.2	64.2	64.8	14.9	9.2	17.6	57	52.1	73.6	76.2	91.9	105	138.4	108.8	89.7	81.3	53.8	49.5	32.3	22.4	11	3.6	3.3	2.7	1.5	0.9	0.8
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-521.4	-992.9	-26.5	-1265.4	-468.3	5.9	12	40.8	-2.6	3.5	12	9.9	20.4	-25.4	-57.4	-8.8	-10.2	2.4	2.3	2.2	3.1	1.8	1.8	11.4	8.7	-0.1	0	-0.1	-0.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	101.3	94.5	41.9	90.8	-3.2	5.9	12.4	42.4	-2.3	3.6	12.1	9.9	21.1	3.8	6.5	5.3	-3.3	9.5	-4.8	6.6	8.2	2.4	2.3	16.1	8.2	0	4.2	3.8	3.6
income-statement-row.row.total-operating-expenses	-521.4	-992.9	-26.5	-1265.4	-468.3	5.9	12	40.8	-2.6	3.5	12	9.9	20.4	-25.4	-57.4	-8.8	-10.2	2.4	2.3	2.2	3.1	1.8	1.8	11.4	8.7	-0.1	0	-0.1	-0.1
income-statement-row.row.interest-expense	18.9	14.5	20.2	64.2	64.8	14.9	9.2	17.6	57	52.1	73.6	76.2	91.9	105	138.4	108.8	89.7	81.3	53.8	49.5	32.3	22.4	11	3.6	3.3	2.7	1.5	0.9	0.8
income-statement-row.row.depreciation-and-amortization	46.9	47.4	28.2	-210.7	44.3	42.7	42.2	57.5	46.7	46.6	46.5	49.2	47.8	45.6	85.8	100.8	87.5	86.6	62.4	33.3	27.8	18.8	18.6	15.7	5.3	2.7	-7	-7.2	-6.2
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	218.6	59.9	109.7	-106.2	-702.8	4.1	24.4	97.3	35.8	18	22.5	-201	-104.3	100.6	-110	46.8	-160.8	12.2	109.3	109.3	78.6	98.8	92.7	50.2	31.4	46.1	47.8	38.4	22.9
income-statement-row.row.income-before-tax	-302.7	-933	83.2	-1371.5	-701.5	10.1	36.4	138.1	33.2	21.5	34.5	-191.1	-83.9	75.2	-167.4	38	-171	14.6	111.6	111.5	81.7	100.7	94.5	61.6	40.2	46.1	47.8	38.3	22.9
income-statement-row.row.income-tax-expense	33.9	35.5	21.1	11.3	39.3	-3.9	19.9	35.5	10.2	9.1	8.7	-3.6	-12.1	29.9	18.2	11.8	9.9	10.4	9.1	17.3	12.9	7.3	5.5	12.3	9.5	6.9	7.2	3	3
income-statement-row.row.net-income	-336.6	-968.5	58.3	-1382.8	-706	10.2	12.9	102.5	26.1	12.2	24.1	-178.4	-74.1	39.9	-198.4	11.7	-183.4	0.9	7.1	90.1	66.8	92.5	87.6	48.3	29	26.4	28.9	26.3	18.4